Clinical trial NCT05099042: Evaluating Quebec's Red-Cross Intervention
Official title: Seniors Waiting for Medico-social Care at the CIUSSS-Centre-Sud de l'île de Montréal's Territory Waiting List (GACO) : Evaluation of the Intervention of a New Partner - Quebec's Red-Cross
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Social Isolation
Aging
Lead sponsor: Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Sponsor class: OTHER_GOV
First posted: 2021-10-29
Enrollment: 300
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 to 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) concludes that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs.

Thus the principal investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital platform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. The principal investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable.

Hence, the principal investigator hypothesizes that ESOGER is a clinical tool enabling first line care by the Red-Cross to vulnerable EP without a family doctor, which will lead to an improvement in their health, autonomy and quality of life. Moreover, the principal investigator also hypothesizes that for a better deployment, the tool needs to be adapted to Red-Cross' need and EP service providers.


Eligibility criteria: Inclusion Criteria:

* Aged 65 and more
* Living at home
* Be registered at the waiting list of GACO at the CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL)

Exclusion Criteria:

* Principal address outside of the CCSMTL territory
* Participate at another clinical trial, to avoid interferences
* Not understand written or spoken French or English, questionnaires are only available in French and English.

Primary outcomes:
measure: COVID-19 symptoms assessed through a questionnaire
timeFrame: 3 months
measure: psychological fraility
timeFrame: 3 months
measure: Social health measured through a questionnaire
timeFrame: 3 months
measure: Socio-economic characteristics
timeFrame: 3 months
measure: Participant's Quality of life
timeFrame: 3 months
measure: Autonomy
timeFrame: 3 months
Secondary outcomes:
measure: Caregiver burden
timeFrame: 3 months
Other outcomes:
Locations:
city: Montréal
country: Canada
facility: CRIUGM
state: Quebec
Study officials:
References: